Dec. 22, 2022--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis, San Francisco, CA on January 9-12, 2023.
Quantum-Si’s management will present on Thursday, January 12 at 10:30 am Pacific Standard Time. The discussions will cover recent company developments, including the recently-announced commercial availability of Quantum-Si’s groundbreaking Platinum™ instrument, which is the first system to enable next-generation, single-molecule protein sequencing.
A live and archived webcast of the events will be available in the Investors section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
| Last Trade: | US$1.20 |
| Daily Change: | 0.01 0.84 |
| Daily Volume: | 2,250,416 |
| Market Cap: | US$166.080M |
February 18, 2025 February 13, 2025 January 28, 2025 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
